Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bonner

Showing results (241-250 of 318) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2003
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderlySteven E Schild, Philip J Stella, Susan M Geyer, et al.
ACS Chemical Neuroscience|January 22, 2013
Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligandsJose I Juncosa, Martin Hansen, Lisa A Bonner, et al.
Biochemical and Biophysical Research Communications|July 18, 2019
Differential escape mechanisms in cetuximab-resistant head and neck cancer cellsChristopher D Willey, Joshua C Anderson, Hoa Q Trummell, et al.
Cancer|March 15, 1995
Prophylactic cranial irradiation in limited-stage small cell lung cancerV Liengswangwong, J A Bonner, E G Shaw, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trialJames A Bonner, Jordi Giralt, Paul M Harari, et al.
Bioconjugate Chemistry|November 18, 2004
Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structureAhmad Safavy, Gunda I Georg, David Vander Velde, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1)Jeff A Sloan, James A Bonner, Shauna L Hillman, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cellsJames A Bonner, Donald J Buchsbaum, Buck E Rogers, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2008
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancerJimmy J Caudell, Philip E Schaner, Ruby F Meredith, et al.
Acta Haematologica|January 1, 1995
Management of stage IE primary gastric lymphomaE D Durr, J A Bonner, J G Strickler, et al.
Pageof 32

Showing results (241-250 of 318) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2003
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderlySteven E Schild, Philip J Stella, Susan M Geyer, et al.
ACS Chemical Neuroscience|January 22, 2013
Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligandsJose I Juncosa, Martin Hansen, Lisa A Bonner, et al.
Biochemical and Biophysical Research Communications|July 18, 2019
Differential escape mechanisms in cetuximab-resistant head and neck cancer cellsChristopher D Willey, Joshua C Anderson, Hoa Q Trummell, et al.
Cancer|March 15, 1995
Prophylactic cranial irradiation in limited-stage small cell lung cancerV Liengswangwong, J A Bonner, E G Shaw, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trialJames A Bonner, Jordi Giralt, Paul M Harari, et al.
Bioconjugate Chemistry|November 18, 2004
Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structureAhmad Safavy, Gunda I Georg, David Vander Velde, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1)Jeff A Sloan, James A Bonner, Shauna L Hillman, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cellsJames A Bonner, Donald J Buchsbaum, Buck E Rogers, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2008
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancerJimmy J Caudell, Philip E Schaner, Ruby F Meredith, et al.
Acta Haematologica|January 1, 1995
Management of stage IE primary gastric lymphomaE D Durr, J A Bonner, J G Strickler, et al.
Pageof 32